My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Greater Columbia Opoid Grant
>
Meetings
>
2023
>
06. June
>
2023-06-20 10:00 AM - Commissioners' Agenda
>
Greater Columbia Opoid Grant
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
6/15/2023 1:56:28 PM
Creation date
6/15/2023 1:54:35 PM
Metadata
Fields
Template:
Meeting
Date
6/20/2023
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Request to Approve a Memorandum of Understanding between the Greater Columbia Region Municipalities to Establish and Opioid Abatement Council
Order
13
Placement
Consent Agenda
Row ID
104780
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
16
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Exhibit A <br />OPIOID ABATEMENT STRATEGIES <br />Participating Local Governments that receive a direct payment maintain full <br />discretion over the use and distribution of their allocation of Opioid Funds, <br />provided the Opioid Funds are used solely for Approved Purposes. Reasonable <br />administrative costs for a Participating Local Government to administer its <br />allocation of Opioid Funds shall not exceed actual costs or 10% of the <br />Participating Local Government's allocation Opioid Funds, whichever is less. <br />L PART ONE: TREATMENT <br />A. TREAT OPIOID USE DISORDER (OUD <br />Support treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use <br />Disorder or Mental Health (SUD/MH) conditions. Co -usage, and/or co -addiction through <br />evidence -based, evidence -informed, or promising programs or strategies that may include, <br />but are not limited to, the following: <br />1. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions, <br />co -usage, and/or co -addiction. Including all forms of Medication -Assisted Treatment <br />(MAT) approved by the U.S. Food and Drug Administration. <br />2. Support and reimburse services that include the full American Society of Addiction <br />Medicine (ASAM) continuum of care for OUD and any co-occurring SUD/MH <br />conditions, co -usage, and/or co -addiction, including but not limited to: <br />a. Medication -Assisted Treatment (MAT); <br />b. Abstinence -based treatment; <br />c. Treatment, recovery, or other services provided by states, subdivisions, <br />community health centers; non -for -profit providers; or for -profit providers; <br />d. Treatment by providers that focus on OUD treatment as well as treatment by <br />providers that offer OUD treatment along with treatment for other SUD/MH <br />condition, co -usage, and/or co -addiction; or <br />
The URL can be used to link to this page
Your browser does not support the video tag.